SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $85,712 | -25.4% | 24,701 | 0.0% | 0.00% | – |
| Q2 2023 | $114,860 | +24.6% | 24,701 | +23.8% | 0.00% | – |
| Q1 2023 | $92,206 | -42.8% | 19,958 | 0.0% | 0.00% | – |
| Q4 2022 | $161,261 | +45.6% | 19,958 | 0.0% | 0.00% | – |
| Q3 2022 | $110,767 | +24.5% | 19,958 | +16.6% | 0.00% | – |
| Q2 2022 | $89,000 | -36.9% | 17,110 | 0.0% | 0.00% | – |
| Q1 2022 | $141,000 | -44.7% | 17,110 | 0.0% | 0.00% | – |
| Q4 2021 | $255,000 | -20.6% | 17,110 | +0.8% | 0.00% | -100.0% |
| Q3 2021 | $321,000 | +1.6% | 16,982 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $316,000 | +1.9% | 16,982 | +24.7% | 0.00% | 0.0% |
| Q1 2021 | $310,000 | +21.6% | 13,615 | +15.8% | 0.00% | 0.0% |
| Q4 2020 | $255,000 | – | 11,760 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |